CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Implementation of Stereotactic Ablative Radiotherapy in Canada

Last updated: December 3, 2020
Project Number: ES0352-000
Product Line: Environmental Scans
Result type: Report

CADTH is undertaking an Environmental Scan to support a health technology assessment project regarding the use of stereotactic ablative radiotherapy (SABR) in Canada and to provide an understanding of the current practice regarding the use of SABR, as well as the implementation considerations for expanding the use of SABR for the treatment of oligometastatic cancer.

The key objectives of this Environmental Scan are to:

  • identify and describe how SABR technology is being accessed and used by Canadian jurisdictions
  • identify and describe the systems that are in place to manage SABR treatment for patients with oligometastatic cancer, including training and resource allocation
  • compare the application of SABR technology in treating localized disease versus oligometastatic disease in terms of the infrastructure required for delivery
  • identify and describe the barriers and facilitators to the implementation of SABR treatment for patients with oligometastatic cancer.

Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.

The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.